SHILPAMED.NSSHILPAMED.NSNSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank57
3Y CAGR+2.2%
5Y CAGR+8.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+2.2%/yr
vs -10.6%/yr prior
5Y CAGR
+8.1%/yr
Recent deceleration
Acceleration
+12.8pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
2025$4.10B-7.5%
2024$4.44B-51.2%
2023$9.09B+136.7%
2022$3.84B+41.9%
2021$2.71B-2.5%
2020$2.78B-49.3%
2019$5.48B-8.9%
2018$6.01B+5.7%
2017$5.69B+49.3%
2016$3.81B-